# Blinding and Adverse Effects of Ultrasonic Vagus Nerve Stimulation (U-VNS)

> **NCT07091812** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Nottingham** · enrollment: 20 (actual)

## Conditions studied

- U-VNS
- Sham U-VNS

## Interventions

- **DEVICE:** Ultrasound Vagus Nerve Stimulation (U-VNS)
- **DEVICE:** Sham U-VNS

## Key facts

- **NCT ID:** NCT07091812
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-10
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-06-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091812, "Blinding and Adverse Effects of Ultrasonic Vagus Nerve Stimulation (U-VNS)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07091812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*